The SENTINEL has learned of a new treatment which may be a major advance in preventing pneumocystis in persons with AIDS. About 100 patients in New York and 30 in San Francisco are now using this experimental therapy, but so far there has been little publicity and most physicians are unfamiliar with it. Until the curre
An experimental substance called peptide T may represent a major research breakthrough, and it could be available soon for human use. Peptides are short chains of amino acids (the building blocks of proteins). Peptide T is a chain of eight amino acids, namely Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr (using conventional three-le
Last week the manufacturer of ribavirin released key results from a double-blind study of that drug s effectiveness in preventing persons with lymphadenopathy syndrome from progressing to AIDS. Although questions remain, the results are good. Unfortunately much confusion grew from the ribavirin announcement. The extens
The statement below was written by a friend of mine who was near death from AIDS in early 1986, but now is healthy. His experience adds urgency to the increasing weight of scientific evidence suggesting that AL 721 can be a major help to some people with AIDS or ARC. (This treatment, extracted entirely from egg yolks,
This information is designed to support, not replace, the relationship that exists between you and your doctor.